Literature DB >> 25926648

Recombination of Globally Circulating Varicella-Zoster Virus.

Peter Norberg, Daniel P Depledge, Samit Kundu, Claire Atkinson, Julianne Brown, Tanzina Haque, Yusuf Hussaini, Eithne MacMahon, Pamela Molyneaux, Vassiliki Papaevangelou, Nitu Sengupta, Evelyn S C Koay, Julian W Tang, Gillian S Underhill, Anna Grahn, Marie Studahl, Judith Breuer, Tomas Bergström.   

Abstract

UNLABELLED: Varicella-zoster virus (VZV) is a human herpesvirus, which during primary infection typically causes varicella (chicken pox) and establishes lifelong latency in sensory and autonomic ganglia. Later in life, the virus may reactivate to cause herpes zoster (HZ; also known as shingles). To prevent these diseases, a live-attenuated heterogeneous vaccine preparation, vOka, is used routinely in many countries worldwide. Recent studies of another alphaherpes virus, infectious laryngotracheitis virus, demonstrate that live-attenuated vaccine strains can recombine in vivo, creating virulent progeny. These findings raised concerns about using attenuated herpesvirus vaccines under conditions that favor recombination. To investigate whether VZV may undergo recombination, which is a prerequisite for VZV vaccination to create such conditions, we here analyzed 115 complete VZV genomes. Our results demonstrate that recombination occurs frequently for VZV. It thus seems that VZV is fully capable of recombination if given the opportunity, which may have important implications for continued VZV vaccination. Although no interclade vaccine wild-type recombinant strains were found, intraclade recombinants were frequently detected in clade 2, which harbors the vaccine strains, suggesting that the vaccine strains have already been involved in recombination events, either in vivo or in vitro during passages in cell culture. Finally, previous partial and complete genomic studies have described strains that do not cluster phylogenetically to any of the five established clades. The additional VZV strains sequenced here, in combination with those previously published, have enabled us to formally define a novel sixth VZV clade. IMPORTANCE: Although genetic recombination has been demonstrated to frequently occur for other human alphaherpesviruses, herpes simplex viruses 1 and 2, only a few ancient and isolated recent recombination events have hitherto been demonstrated for VZV. In the present study, we demonstrate that VZV also frequently undergoes genetic recombination, including strains belonging to the clade containing the vOKA strain.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926648      PMCID: PMC4473579          DOI: 10.1128/JVI.00437-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  62 in total

Review 1.  The epidemiology of varicella-zoster virus infections.

Authors:  M Wharton
Journal:  Infect Dis Clin North Am       Date:  1996-09       Impact factor: 5.982

2.  Live vaccine used to prevent the spread of varicella in children in hospital.

Authors:  M Takahashi; T Otsuka; Y Okuno; Y Asano; T Yazaki
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  Recombination in tissue culture between varicella-zoster virus strains.

Authors:  D E Dohner; S G Adams; L D Gelb
Journal:  J Med Virol       Date:  1988-03       Impact factor: 2.327

4.  Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations.

Authors:  T Bergström
Journal:  Scand J Infect Dis Suppl       Date:  1996

5.  Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity.

Authors:  Y Gomi; T Imagawa; M Takahashi; K Yamanishi
Journal:  J Med Virol       Date:  2000-08       Impact factor: 2.327

6.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

7.  Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions.

Authors:  J M Echevarría; I Casas; A Tenorio; F de Ory; P Martínez-Martín
Journal:  J Med Virol       Date:  1994-08       Impact factor: 2.327

Review 8.  Zoster sine herpete, a clinical variant.

Authors:  D H Gilden; R R Wright; S A Schneck; J M Gwaltney; R Mahalingam
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

9.  Direct isolation and identification of recombinant pseudorabies virus strains from tissues of experimentally co-infected swine.

Authors:  C A Dangler; L M Henderson; L A Bowman; R E Deaver
Journal:  Am J Vet Res       Date:  1993-04       Impact factor: 1.156

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  35 in total

1.  Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.

Authors:  Christine Johnston; Amalia Magaret; Pavitra Roychoudhury; Alexander L Greninger; Anqi Cheng; Kurt Diem; Matthew P Fitzgibbon; Meei-Li Huang; Stacy Selke; Jairam R Lingappa; Connie Celum; Keith R Jerome; Anna Wald; David M Koelle
Journal:  Virology       Date:  2017-07-13       Impact factor: 3.616

2.  Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons.

Authors:  Nancy J Jensen; Pierre Rivailler; Hung Fu Tseng; Mark L Quinlivan; Kay Radford; Jennifer Folster; Rafael Harpaz; Philip LaRussa; Steven Jacobsen; D Scott Schmid
Journal:  J Gen Virol       Date:  2017-06-14       Impact factor: 3.891

3.  Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.

Authors:  Kosuke Kawai; Barbara P Yawn; Peter Wollan; Rafael Harpaz
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

4.  Characterization and phylogenetic analysis of Varicella-zoster virus strains isolated from Korean patients.

Authors:  Min Ho Kim; Jeong Seon Jeon; In Kyo Kim; Ji Seon Park; Hosun Park; Ok Sarah Shin; Chan Hee Lee
Journal:  J Microbiol       Date:  2017-07-28       Impact factor: 3.422

5.  Focal herpes zoster encephalitis without a rash: diagnostic confusion between astrogliosis and low-grade glioma.

Authors:  Geoffrey C Halling; Charles Grose
Journal:  Expert Rev Anti Infect Ther       Date:  2016-10-27       Impact factor: 5.091

6.  Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1.

Authors:  P K Vaz; J Horsington; C A Hartley; G F Browning; N P Ficorilli; M J Studdert; J R Gilkerson; J M Devlin
Journal:  J Gen Virol       Date:  2015-12-21       Impact factor: 3.891

7.  Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion.

Authors:  Randall J Cohrs; Katherine S Lee; Addilynn Beach; Bridget Sanford; Nicholas L Baird; Christina Como; Chiharu Graybill; Dallas Jones; Eden Tekeste; Mitchell Ballard; Xiaomi Chen; David Yalacki; Seth Frietze; Kenneth Jones; Tihana Lenac Rovis; Stipan Jonjić; Jürgen Haas; Don Gilden
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

8.  Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity.

Authors:  Emily E Marshall; Daniel Malouli; Scott G Hansen; Roxanne M Gilbride; Colette M Hughes; Abigail B Ventura; Emily Ainslie; Andrea N Selseth; Julia C Ford; David Burke; Craig N Kreklywich; Jennie Womack; Alfred W Legasse; Michael K Axthelm; Christoph Kahl; Daniel Streblow; Paul T Edlefsen; Louis J Picker; Klaus Früh
Journal:  Sci Transl Med       Date:  2019-07-17       Impact factor: 17.956

9.  Genomic, Recombinational and Phylogenetic Characterization of Global Feline Herpesvirus 1 Isolates.

Authors:  Andrew C Lewin; Aaron W Kolb; Gillian J McLellan; Ellison Bentley; Kristen A Bernard; Sandra P Newbury; Curtis R Brandt
Journal:  Virology       Date:  2018-03-30       Impact factor: 3.616

Review 10.  Alphaherpesvirus Genomics: Past, Present and Future.

Authors:  Chad V Kuny; Moriah L Szpara
Journal:  Curr Issues Mol Biol       Date:  2020-11-07       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.